Frequency of Hepatitis C Virus in Chronic Kidney Disease Patients on Regular Hemo Dialysis at Tertiary Care Hospital
DOI:
https://doi.org/10.70749/ijbr.v3i7.2450Keywords:
Hepatitis C Virus infection, hemodialysis, chronic kidney disease, hypertension, prevalenceAbstract
Introduction: The hepatitis C virus (HCV) is the significant cause of morbidity and mortality in patients on haemodialysis. Hemodialysis patients are also in a high risk of getting infected with HCV and the infection rate is much higher when compared to non-haemodialysis patients. The purpose of the research is to determine the frequency of Hepatitis C Virus (HCV) infection and determine the risk factors in the case of chronic kidney disease (CKD) patients receiving routine haemodialysis. Subjects and Methods: It was a cross-sectional study conducted at the Department of Medicine, DHQ Teaching Hospital/Gomal Medical College, Dera Ismail Khan between December 2024 and May 2025. One hundred and one adult patients with chronic kidney disease of stage 4 or 5 who were receiving maintenance haemodialysis were recruited. The diagnosis of HCV infection was made by the third generation Enzyme-Linked Immunosorbent Assay (ELISA) of anti-HCV antibodies. Demographic and clinical information was collected and stratified analysis was done to establish relationship with HCV status using Chi-square test. Results: The overall rate of the HCV infection was 28.1% (34 out of 121). The population average age was 38.23 years old with a standard deviation of 12.55 and majority of the population being male (60.3%) and 73.6% were urban inhabitants. Stratification revealed significant negative relationship between hypertension and HCV status and more so, hypertension was more prevalent among non-hypertensive (37.5% vs. 20.0%, p=0.033). Residency was found to have a significant trend, with a much higher prevalence of HCV found in rural patients (40.6%) as compared to urban patients (23.6%, p=0.066). There were no significant relationships of HCV status and gender, age, BMI, diabetes, or CKD length. Conclusions: According to our study, the prevalence of haemodialysis population with regard to HCV infection is high. The significant association between the absence of hypertension and the significant pattern of living in rural areas indicates the need to have better, assessed infection control strategies and targeted screening strategies on the high-risk groups with a view to reducing the burden of HCV among the at-risk group.
Downloads
References
1. Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease—a systematic review and meta-analysis. PloS one. 2018;11(7):e0158765.
https://doi.org/10.1371/journal.pone.0158765
2. Segall L, Nistor I, Van Biesen W, Brown EA, Heaf JG, Lindley E, et al. Dialysis modality choice in elderly patients with end-stage renal disease: a narrative review of the available evidence. NDT. 2019;32(1):41-9.
https://doi.org/10.1093/ndt/gfv411
3. Ashuntantang G, Osafo C, Olowu WA, Arogundade F, Niang A, Porter J, et al. Outcomes in adults and children with end-stage kidney disease requiring dialysis in sub Saharan Africa: a systematic review. Lancet Glob Health. 2017;5(4):408-17.
https://doi.org/10.1016/s2214-109x(17)30057-8
4. Bahri F, Kargar AK, Ghasemzadeh I, Shoja S, Gouklani H. Hepatitis viruses B and D and human immunodeficiency virus infections in hemodialysis patients in the South of Iran: prevalence and genotypes. Hepat Mon. 2019;16(1):e32971.
https://doi.org/10.5812/hepatmon.32971
5. Dar GU, Qadeer MI, Chudhary SA, Aijaz D, Imtiaz S, Naveed T. Frequency of HbsAg and Anti-HCV among hemodialysis patients in three General Hospitals of Azad Jammu and Kashmir State. Int J Front Sci. 2020;4(1):52-4.
https://doi.org/10.37978/tijfs.v4i1.72
6. Umer M, Iqbal M. Hepatitis C virus prevalence and genotype distribution in Pakistan: comprehensive review of recent data. World J Gastroenterol. 2018;22(4):1684-700.
https://doi.org/10.3748/wjg.v22.i4.1684
7. Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2016. Lancet. 2019;388(10049):1081-8.
https://doi.org/10.1016/s0140-6736(16)30579-7
8. Blach S, Zeuzem S, Maims M, Altraif I, Duberg AS. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepato 1. 2018;2(3):161-76.
9. Moin A, Fatima H, Qadir TF. Tackling hepatitis C—Pakistan's road to success. Lancet. 2018;391(10123):834-5.
https://doi.org/10.1016/s0140-6736(18)30462-8
10. Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2020;388(10053):1545-602.
11. Jadoul M, Bieber BA, Martin P, Akiba T, Nwankwo C, Arduino JM, et al. Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients. Kidney Int. 2019 ;95(4):939-47.
https://doi.org/10.1016/j.kint.2018.11.038
12. Barsoum RS, William EA, Khalil SS. Hepatitis C and kidney disease: a narrative review. J Adv Res. 2017;8(2):113-30.
https://doi.org/10.1016/j.jare.2016.07.004
13. Ali N, Hussain W, Hayat A, Shah T, Wen R, Zeb I, et al. Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients: a multicentric study. Eur J Gastroenterol Hepatol. 2019;31(1):29-33.
https://doi.org/10.1097/meg.0000000000001220
14. Mahmud HM, Siddiqui M, Bashir B, Ali SF, Baloch AA, Masroor M. Hemodialysis patients profile at Dow university of health sciences, Karachi. Pakistan. Pak J Med Sci. 2018;30(6):1327-30.
https://doi.org/10.12669/pjms.306.5364
15. Lodhi A, Sajjad A, Mehmood K, Lodhi A, Rizwan S, Ubaid A, et al. Profile and predictors of hepatitis and HIV infection in patients on hemodialysis of Quetta, Pakistan. Drug Discov Ther. 2019;13(5):274-9.
https://doi.org/10.5582/ddt.2019.01044
16. Rathore MA, Saqi MK, Ghani E, Niazi SK, Ahmed F, Hammad H. Hepatitis C Virus Frequency in Hemodialysis Patients at A Tertiary Care Facility in Rawalpindi, Northern Pakistan. Pak Armed Forces Med J. 2024;74(3):861-4.
https://doi.org/10.51253/pafmj.v74i3.10297
17. Zahoor N, Malik A, Zaman M, Shahbaz F, Fatima N, Mustafa MAU. Prevalence of HCV Among Hemodialysis Patients at a Kidney Center, Gujrat: A Gender-Based Comparative Analysis. IJCMCR. 2025;51(5):004.
https://doi.org/10.46998/ijcmcr.2025.51.001274
18. Ghazzawi I, Yassin M, Alsheby H, Sheyyab S, Alqudah B, Alwahadni N. Prevalence of Hepatitis B and C Viruses in Hemodialysis Patients at JRMS. JRMS. 2015;22(2):69-75.
https://doi.org/10.12816/0011376
19. Jasuja S, Gupta AK, Choudhry R, Kher V, Aggarwal DK, Mishra A, et al. Prevalence and associations of hepatitis C viremia in hemodialysis patients at a tertiary care hospital. Indian J Nephrol. 2009;19(2):62-7.
https://doi.org/10.4103/0971-4065.53324
20. Timofte D, Dragos D, Balcangiu-Stroescu AE, Tanasescu MD, Balan DG, Avino A, et al. Infection with hepatitis C virus in hemodialysis patients: An overview of the diagnosis and prevention rules within a hemodialysis center (Review). Exp Ther Med. 2020;20(1):109-16.
https://doi.org/10.3892/etm.2020.8606
21. Padilla-Machaca PM, Luna-Victoria E, Cabrera A, Gómez-De la Torre JC, Galloso R, Montes P. Chronic hepatitis C in hemodialysis patients: Prevalence and liver fibrosis impact in the National Center for Renal Health in Peru. ILIVER. 2022;1:141-4.
https://doi.org/10.1016/j.iliver.2022.08.001
22. Kumar K, Das B, Naveed A, Kumar S, Khan MT, Memon R. Prevalence of HCV Infection in End Stage Renal Disease (ESRD) Patients on Maintenance Hemodialysis. Pak J Health Sci. 2023;4(2):95-8.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research

This work is licensed under a Creative Commons Attribution 4.0 International License.